Moberg Pharma AB (CHIX:MOBS) E10: kr49.35 (As of Mar. 2026)


CHIX:MOBS Moberg Pharma AB CHIX:MOBS
59 GF Score
Price kr17.55
GF Value kr23.20
! 1 Warning Sign
View Full Analysis

What is Moberg Pharma AB E10?

Moberg Pharma AB CHIX:MOBS 59 E10 is kr49.35 as of Mar. 2026. GuruFocus rates CHIX:MOBS with a GF Score™ of 59/100 and a GF Value™ of kr23.20. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Moberg Pharma AB's adjusted earnings per share data for the three months ended in Mar. 2026 was kr-0.030. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr49.35 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Moberg Pharma AB's average E10 Growth Rate was -4.20% per year. During the past 3 years, the average E10 Growth Rate was 1.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Moberg Pharma AB was 1.00% per year. The lowest was 1.00% per year. And the median was 1.00% per year.

As of today (2026-07-02), Moberg Pharma AB's current stock price is kr17.55. Moberg Pharma AB's E10 for the quarter that ended in Mar. 2026 was kr49.35. Moberg Pharma AB's Shiller PE Ratio of today is 0.36.

During the past 13 years, the highest Shiller PE Ratio of Moberg Pharma AB was 18.76. The lowest was 0.15. And the median was 0.64.


Moberg Pharma AB  (CHIX:MOBs) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Moberg Pharma AB's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=17.55/49.35
=0.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Moberg Pharma AB was 18.76. The lowest was 0.15. And the median was 0.64.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Moberg Pharma AB E10 Related Terms


Moberg Pharma AB E10 Historical Data

* Premium members only.

The historical data trend for Moberg Pharma AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Moberg Pharma AB E10 Chart

Moberg Pharma AB Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 62.08 37.78 40.96 52.74

Moberg Pharma AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67.23 58.67 59.24 50.41 49.35

CHIX:MOBS vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Moberg Pharma AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moberg Pharma AB Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Moberg Pharma AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Moberg Pharma AB's Shiller PE Ratio falls into.


CHIX:MOBS
59GF Score
Moberg Pharma AB CHIX:MOBS
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Moberg Pharma AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Moberg Pharma AB's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.03/133.3862*133.3862
=-0.030

Current CPI (Mar. 2026) = 133.3862.

Moberg Pharma AB Quarterly Data

per share eps CPI Adj_EPS
201512 0.000 100.276 0.000
201603 -2.277 100.751 -3.015
201606 11.157 101.019 14.732
201609 5.066 101.138 6.681
201612 -1.139 102.022 -1.489
201703 -0.968 102.022 -1.266
201706 -2.562 102.752 -3.326
201709 4.042 103.279 5.220
201712 3.131 103.793 4.024
201803 0.683 103.962 0.876
201806 1.537 104.875 1.955
201809 0.683 105.679 0.862
201812 3.586 105.912 4.516
201903 181.877 105.886 229.113
201906 19.926 106.742 24.900
201909 10.019 107.214 12.465
202003 -1.159 106.563 -1.451
202006 -1.802 107.498 -2.236
202009 -1.609 107.635 -1.994
202103 3.025 108.360 3.724
202106 -0.533 108.928 -0.653
202109 -0.600 110.338 -0.725
202112 -0.667 112.486 -0.791
202203 -0.667 114.825 -0.775
202206 -0.413 118.384 -0.465
202209 -0.287 122.296 -0.313
202212 -0.153 126.365 -0.162
202303 -0.340 127.042 -0.357
202306 -0.260 129.407 -0.268
202309 -0.360 130.224 -0.369
202312 -0.230 131.912 -0.233
202403 -0.230 132.205 -0.232
202406 -0.130 132.716 -0.131
202409 -0.030 132.304 -0.030
202412 -5.210 132.987 -5.226
202503 -0.060 132.825 -0.060
202506 -0.160 133.699 -0.160
202509 -0.090 133.482 -0.090
202512 -0.270 133.386 -0.270
202603 -0.030 133.386 -0.030

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of kr49.35 mean?
Moberg Pharma AB (CHIX:MOBS) has a E10 of kr49.35 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Moberg Pharma AB and its competitors.
Is Moberg Pharma AB's E10 too high?
Moberg Pharma AB's current E10 is kr49.35. Overall, Moberg Pharma AB has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Moberg Pharma AB's E10 compare to ZTS and UTHR?
Moberg Pharma AB's E10 of kr49.35 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Moberg Pharma AB and its competitors. Moberg Pharma AB's current E10 is kr49.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Moberg Pharma AB stock overvalued right now?
Moberg Pharma AB (CHIX:MOBS) has a current E10 of kr49.35. The stock's GF Value™ is kr23.20, compared to a current price of kr17.55 — trading 24.4% below its estimated fair value. The current E10 is kr49.35. Moberg Pharma AB's overall GF Score™ is 59/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Moberg Pharma AB (CHIX:MOBS), the current E10 is kr49.35 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Moberg Pharma AB (CHIX:MOBS) Overvalued in 2026?

Based on GuruFocus' analysis, Moberg Pharma AB stock appears to be undervalued. The current stock price of kr17.55 is trading 24.4% below its estimated GF Value™ of kr23.20.

Key valuation signals for CHIX:MOBS:

  • E10: kr49.35
  • GF Value™: kr23.20 vs. price of kr17.55 (24.4% below fair value)
  • GF Score™: 59/100 with 1 warning sign

No single metric tells the full story. See the CHIX:MOBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Moberg Pharma AB Business Description

Other Exchanges MBGPF:USAMOB:Sweden
Address Gustavslundsvagen 42, 5th Floor, Bromma, Stockholm, SWE, SE-167 51
Moberg Pharma AB is a Swedish pharmaceutical company which develops and commercializes proprietary pharmaceuticals based on proven substances. The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus. The Company's main product, MOB-015, is a novel topical treatment for onychomycosis It has a single operating segment, the development, and commercialization of medical products. Its geographic areas are Europe, the Americas, and Rest of the world.
59GF Score

Get the complete analysis for CHIX:MOBS

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr17.55
Price
kr23.20
GF Value